Mavacamten will decrease the level or influence of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Progestin and ethinyl estradiol are CYP3A4 substrates. Mavacamten may well lower systemic exposures of ethinyl estradiol and progestin, which may lead to contraceptive failure or a rise in https://aaronx874wgp4.elbloglibre.com/profile